Journal Mobile Options
Table of Contents
Vol. 47, No. 2, 1996
Issue release date: 1996
Brain Behav Evol 1996;47:103–112
(DOI:10.1159/000113231)
Original Paper

Cytochrome Oxidase 'Blobs' and Other Characteristics of Primary Visual Cortex in a Lemuroid Primate, Cheirogaleus medius

Preuss T.M. · Kaas J.H.
Department of Psychology, Vanderbilt University, Nashville, Tenn., USA

Abstract

We recently obtained the brain of a rare lemuroid primate, Cheirogaleus medius. The brain was not perfused before death, but rather fixed by immersion shortly thereafter. In both flat-mounted and transversely sectioned tissue, we were able to clearly demonstrate periodic zones of high cytochrome oxidase (CO) activity in the primary visual cortex, resembling the so-called 'blobs' described in many other primate species. Our results contrast with a previous report indicating that blobs are absent in Cheirogaleus medius and provide support for the view that blobs are an evolutionary specialization of primate visual cortex that evolved only once, early in primate history. In other aspects of architectonic organization, area V1 of this Cheirogaleus individual closely resembles that of other strepsirhine primates, such as Galago. We were able to identify additional divisions of cortex in this individual, including the middle temporal visual area (MT), auditory cortex, and the primary somatosensory area (S1 or area 3b). These observations indicate that valuable neuroanatomical information can, in favorable cases, be obtained from rare mammalian species that die of natural causes in captivity or which must be euthanized, even though the animals have not been perfused.

 goto top of outline Author Contacts

Jon H. Kaas, PhD, Department of Psychology, Vanderbilt University, 111 21st Avenue South Nashville, TN 37240–0009 (USA)


 goto top of outline Article Information

Number of Print Pages : 10


 goto top of outline Publication Details

Brain, Behavior and Evolution

Vol. 47, No. 2, Year 1996 (Cover Date: 1996)

Journal Editor: Wilczynski, W. (Atlanta, Ga.)
ISSN: 0006–8977 (Print), eISSN: 1421–9743 (Online)

For additional information: http://www.karger.com/BBE


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.